13F filer · CIK 1952142
STEMPOINT CAPITAL LP
NEW YORK, NY · filing since Q4 2023 · last filing Aug 14, 2026
Reported value
$580.5M
$-456.4M vs prior
Positions
84
New / sold out
34 / 32
Added / reduced
8 / 42
Turnover
23.9%
buys $193.7M · sells $867.5M
Top-10 weight
41.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | TANGO THERAPEUTICS INC | +821,181 | +204.4% | +$25.7M |
| Added | ERASCA INC | +1,086,191 | +226.4% | +$19.9M |
| New | KINIKSA PHARMACEUTICALS INTL | +209,234 | – | +$13.4M |
| New | FIRST TRACKS BIOTHERAPEUTICS | +622,723 | – | +$12.5M |
| New | ORUKA THERAPEUTICS INC | +116,461 | – | +$11.1M |
| New | CLIMB BIO INC | +742,745 | – | +$9.7M |
| Added | TYRA BIOSCIENCES INC | +246,400 | +63.8% | +$7.9M |
| New | INFLARX NV | +3,228,255 | – | +$7.2M |
| New | OVID THERAPEUTICS INC | +2,417,283 | – | +$6.5M |
| New | EQUILLIUM INC | +2,016,607 | – | +$6.5M |
32 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | SCHOLAR ROCK HLDG CORP | -1,831,846 | -88.5% | $-100.8M |
| Reduced | REVOLUTION MEDICINES INC | -403,321 | -71.6% | $-75.5M |
| Sold out | SYNDAX PHARMACEUTICALS INC | -2,431,486 | -100.0% | $-56.8M |
| Reduced | IMMUNOVANT INC | -1,216,461 | -81.5% | $-46.9M |
| Reduced | ABIVAX SA | -343,925 | -54.8% | $-45.8M |
| Reduced | BIOHAVEN LTD | -2,124,782 | -66.6% | $-31.6M |
| Sold out | MBX BIOSCIENCES INC | -998,938 | -100.0% | $-29.8M |
| Reduced | PRAXIS PRECISION MEDICINES I | -75,291 | -66.9% | $-25.2M |
| Reduced | DEFINIUM THERAPEUTICS INC | -513,842 | -78.9% | $-24.2M |
| Reduced | SPYRE THERAPEUTICS INC | -228,286 | -68.1% | $-20.3M |
64 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | TANGO THERAPEUTICS INCCOM | 1,223,019 | $38.2M | 6.59% |
| 2 | ABIVAX SASPONSORED ADS | 283,657 | $37.8M | 6.51% |
| 3 | REVOLUTION MEDICINES INCCOM | 159,943 | $30.0M | 5.16% |
| 4 | ERASCA INCCOM | 1,565,913 | $28.7M | 4.94% |
| 5 | TYRA BIOSCIENCES INCCOM | 632,754 | $20.2M | 3.48% |
| 6 | DIANTHUS THERAPEUTICS INCCOM | 200,851 | $19.6M | 3.37% |
| 7 | ENLIVEN THERAPEUTICS INCCOM | 346,914 | $17.6M | 3.03% |
| 8 | MINERALYS THERAPEUTICS INCCOM | 602,686 | $16.3M | 2.80% |
| 9 | BIOHAVEN LTDCOM | 1,064,200 | $15.8M | 2.73% |
| 10 | SURROZEN INCCOM NEW | 602,798 | $13.8M | 2.37% |
74 more rows. Subscribe for $29/month to see every row, download the data and use the API.